Viewing StudyNCT00449761



Ignite Creation Date: 2024-05-05 @ 5:23 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00449761
Status: TERMINATED
Last Update Posted: 2021-07-15
First Post: 2007-03-20

Brief Title: Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Leukemia Myeloid Chronic
Keywords:
Name View
oral LBH589 View
Refractory View
Chronic Myeloid View
Leukemia View
accelerated phase View
blast phase blast crisis View
adults View